Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients
- PMID: 15708428
- DOI: 10.1016/j.neurobiolaging.2004.07.016
Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients
Abstract
It is well established that oxidative stress plays a key role in the degenerative neuronal death and progression of Alzheimer's disease (AD), although it is not clear if it is the primary triggering event in the pathogenesis of this disorder. Mild cognitive impairment (MCI) is a clinical condition between normal aging and AD, characterized by a memory deficit without loss of general cognitive and functional abilities. We performed this study by a comet assay analysis to evaluate the level of primary and oxidative DNA damage in two groups of MCI and AD patients, compared to healthy controls. Data showed a significantly higher level of primary DNA damage in leukocytes of AD and also of MCI patients compared to control individuals (average: 2.09+/-0.79 and 2.47+/-1.01, respectively for AD and MCI, versus 1.04+/-0.31 in controls). Moreover, the amount of oxidised DNA bases (both purines and pyrimidines) was significatively higher in the two groups of patients (AD and MCI) compared to controls. Our results give a further indication that oxidative stress, at least at the DNA level, is an earlier event in the pathogenesis of AD.
Comment in
-
Oxidative stress in Alzheimer's disease.Neurobiol Aging. 2005 May;26(5):575-8. doi: 10.1016/j.neurobiolaging.2004.07.017. Neurobiol Aging. 2005. PMID: 15708429 Review. No abstract available.
-
Chronological primacy of oxidative stress in Alzheimer disease.Neurobiol Aging. 2005 May;26(5):579-80. doi: 10.1016/j.neurobiolaging.2004.09.021. Neurobiol Aging. 2005. PMID: 15708430 No abstract available.
-
Peripheral biomarkers of oxidative damage in Alzheimer's disease: the road ahead.Neurobiol Aging. 2005 May;26(5):581-3. doi: 10.1016/j.neurobiolaging.2004.09.020. Neurobiol Aging. 2005. PMID: 15708431 No abstract available.
-
Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment.Neurobiol Aging. 2005 May;26(5):585-6. doi: 10.1016/j.neurobiolaging.2004.09.022. Neurobiol Aging. 2005. PMID: 15708432 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical